June 19, 2024
Amsterdam, the Netherlands - Royal Philips (http://www.philips.com/newscenter)
(NYSE: PHG; AEX: PHIA) today announced that it has completed the cancellation of
4,437,164 of its shares. The cancelled shares were acquired as part of the
completed EUR 1.5 billion share repurchase program for capital reduction
purposes that was announced on July 26, 2021.
Philips' current issued share capital amounts to EUR 187,987,876.80 representing
939,939,384 common shares.
More information is available here (https://www.philips.com/a-
w/about/investor/stock.html#slide_share-repurchases).
For further information, please contact:
Ben Zwirs
Philips External Relations
Tel.: +31 6 1521 3446
E-mail: ben.zwirs@philips.com (mailto:ben.zwirs@philips.com)
Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com (mailto:dorin.danu@philips.com)
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company
focused on improving people's health and well-being through meaningful
innovation. Philips' patient- and people-centric innovation leverages advanced
technology and deep clinical and consumer insights to deliver personal health
solutions for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the home. Headquartered in the
Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-
guided therapy, monitoring and enterprise informatics, as well as in personal
health. Philips generated 2023 sales of EUR 18.2 billion and employs
approximately 69,100 employees with sales and services in more than 100
countries. News about Philips can be found at www.philips.com/newscenter
(https://www.philips.com/a-w/about/news/home.html).
Forward-looking statements
This release contains certain forward-looking statements with respect to the
financial condition, results of operations and business of Philips and certain
of the plans and objectives of Philips with respect to these items. Examples of
forward-looking statements include statements made about the strategy, estimates
of sales growth, future EBITA, future developments in Philips' organic business
and the completion of acquisitions and divestments. By their nature, these
statements involve risk and uncertainty because they relate to future events and
circumstances and there are many factors that could cause actual results and
developments to differ materially from those expressed or implied by these
statements.
Â